Norvasc is a medication used to treat high blood pressure (hypertension). Its generic name is amlodipine, a calcium ion antagonist that can be used to lower blood pressure and treat angina. The pharmacological action of a calcium ion antagonist works primarily on the peripheral arteries by relaxing the blood vessels to lower blood pressure. It can block an influx of calcium ions into the cardiac and vascular smooth muscle cells to reduce vasoconstriction and indirectly induce vasodilatation, allowing more blood to flow smoothly in the vessels, and finally decreasing blood pressure.

As for the heart, the calcium ion antagonist can decrease cardiac contractility by dilating the peripheral arterioles to reduce the consumption of energy and increase myocardial oxygen and blood supply. This can prevent the heart from suffering from necrosis caused by hypoxia and also indirectly help prevent and improve symptoms of ischemic heart disease such as angina, etc.

Amlodipine acts gently to lower blood pressure, without causing a rapid decline in the blood pressure to the victim who may thus suffer from excessively fast heartbeat or palpitations, or even angina. According to clinical reports, 88% of the victims who took this medication were found to return to normal blood pressure, and then recover stable blood pressure eight days after that.  The discomfort of their hearts were thus able to be relieved. Norvasc is a long-acting drug, and because of the sustained therapeutic action, it is convenient to take the medication once a day.

The side effects of Norvasc include headache, somnolence, stomachache, constipation, and fatigue, etc. The severe side effects include excessively fast or slow (<50) heartbeat, skin rash, dyspnea, chest pain, pulmonary edema, dizziness, muscle cramps, and jaundice, etc.

In 1989, Mr. Yuan Lin discovered the Absolutely Constant Energy Source (ACES). He can utilize ACES to activate the genome responsible for inheritance, development and performance of body functions in the human body to control specific amino acid sequences and protein peptide chain formation processes, directing cell division, replication and new organelle formation. ACES was also applied to induce changes in the irreversible process of spontaneous biochemical reactions of carbohydrates, lipids, proteins, amino acids, enzymes, nucleic acids, vitamins, hormones, and trace elements. Mr. Yuan Lin thus had his body experience an unprecedented leap forward in human evolution, which has thoroughly changed the human biological form, structure, and habits inherited over billions of years, to become the first successfully-evolved New Human Line.

The purpose of this experiment is to prove that Mr. Yuan Lin, the first successfully-evolved New Human Line, can utilize the Absolutely Constant Energy Source (ACES) to activate Norvasc and change its concentration without any change in its molecular weight, structural formula, and conformation, at 25℃, 1.0 atm, and pH 7.0, in a confined and isolated space, and with no contact with catalysts, biologically active substances, chemical substances, and physical action forces, and by means of changes in the concentration, to control the biochemical reactions induced by Norvasc so as to maximize its efficacy in the human body at the lowest dose, reduce or totally eliminate the side effects, and avoid adverse medical reactions.

Table 1. Comparison of the absorbance between two treatments at 200 nm

From the above experimental results, we can see that there is significant difference (p= 0.05) in the concentration between the control samples and the samples treated with ACES by Mr. Yuan Lin. It proved that Mr. Yuan Lin, the New Human Line, can utilize the Absolutely Constant Energy Source and the new biological engineering techniques to activate Norvasc and change its concentration, and also, by means of changes in the concentration, to control the biochemical reactions induced by Norvasc so as to maximize its efficacy in the human body at the lowest dose, reduce or totally eliminate the side effects, and avoid adverse medical reactions.

References：